AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26421525
Drug: Low-intensity laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity laser treatment
Trial: 14992903
Drug: Pexelizumab (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pexelizumab (2.0 mg/kg bolus plus 0.05 mg/kg/h infusion for 24 hours)
Trial: 11720319
Drug: Metronidazole 20
RxNorm normalized name: metronidazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 20 mg/kg/d for 2 weeks (n = 9)
Trial: 9385282
Drug: Nasal calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal calcitonin 200 IU per day, divided in 2 doses
Trial: 23464664
Drug: Teneligliptin 40
RxNorm normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Teneligliptin 40 mg
Trial: 15708690
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two capsules per day)
Trial: 23881337
Drug: Behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural therapy
Trial: 11579192
Drug: Both antipsychotic
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both antipsychotic medication and behavioural therapy
Trial: 3450522
Drug: Nitrendipine (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (twice daily)
Trial: 3450522
Drug: Nitrendipine (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (once daily)
Trial: 29373235
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (1 mg/kg per day for 3 days)
Trial: 27825313
Drug: Pharmacist medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist medication therapy management (MTM)
Trial: 25693889
Drug: S(+)‐ketamine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(+)‐ketamine at 120 ng/mL and 240 ng/mL
Trial: 23669628
Drug: High-dose folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose folic acid (4 mg/day)
Trial: 23669628
Drug: Low-dose folic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose folic acid (0.4 mg/day)
Trial: 19032127
Drug: Budesonide/formoterol maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol maintenance and reliever therapy
Trial: 21679353
Drug: Conventional best
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional best standard treatment (CBST)
Trial: 12890205
Drug: 20% DFO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% DFO in aqueous cream
Trial: 10702175
Drug: Carotenoid supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotenoid supplement (25 mg total carotenoids/d)
Trial: 10702175
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of carotenoids and vitamin E (335 mg RRR-alpha-tocopherol/d)
Trial: 6367415
Drug: Gallopamil 150
RxNorm normalized name: gallopamil
DrugBank: Gallopamil (DB12923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 150 mg/day
Trial: 17526166
Drug: Comprehensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive therapy (control group)
Trial: 15657021
Drug: Self-Monitoring of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-Monitoring of Blood Glucose (SMBG) + Hypoglycemia Anticipation, Awareness and Treatment Training (HAATT)
Trial: 23591599
Drug: Vedolizumab 2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vedolizumab 2, 6, or 10 mg/kg on days 1, 15, and 43, followed by maintenance dosing every 8 weeks
Trial: 16205924
Drug: 9NC administered
RxNorm normalized name: 9NC
DrugBank: Rubitecan (DB06159)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9NC administered with food (standard meal)
Trial: 16205924
Drug: 9NC administered
RxNorm normalized name: 9NC
DrugBank: Rubitecan (DB06159)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9NC administered under fasting conditions
Trial: 16205924
Drug: 9AC administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9AC administered with food (standard meal)
Trial: 16205924
Drug: 9AC administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9AC administered under fasting conditions
Trial: 18414916
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg morphine
Trial: 12666001
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg morphine + 50 microg clonidine
Trial: 12666001
Drug: Clonidine (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (combined with morphine)
Trial: 9773721
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (Humulin R)
Trial: 2953174
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion (0.04 microgram/kg/min) in hypertensive men (n = 13)
Trial: 19469799
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg GTPs twice daily
Trial: 19469799
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg GTPs
Trial: 8268525
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (50 mg/kg administered just before and after CPB, and every 90 minutes during CPB)
Trial: 22381987
Drug: Computerized insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Computerized insulin dose calculator
Trial: 10478579
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion with normal saline
Trial: 21399902
Drug: Clonidine 0.1
RxNorm normalized name: clonidine 0.17 MG
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 0.1 mg
Trial: 6311306
Drug: Nabilone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (3 mg orally three times a day, starting the day before cis-platinum and ending the day after)
Trial: 6311306
Drug: Chlorpromazine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (12.5 mg IM, 15 minutes before cis-platinum)
Trial: 21813629
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg at induction followed by 0.3 mg/kg/h infusion)
Trial: 10529580
Drug: Kneippism (custom‐tailored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kneippism (custom‐tailored combination of therapies comprising hydrotherapy, kinesiotherapy, phytotherapy, dietetics, 'ordnungstherapie', and continued disease‐specific standard treatment)
Trial: 6978270
Drug: Indoprofen 800
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 800 mg daily
Trial: 790553
Drug: Indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100 mg daily
Trial: 31896686
Drug: Chlorambucil or
RxNorm normalized name: chlorambucil Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorambucil or rituximab or chlorambucil plus rituximab (systemic treatment)
Trial: 31242926
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment and rehabilitation
Trial: 31650182
Drug: Elagolix 100
RxNorm normalized name: ELAGOLIX
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Elagolix 100 mg BID
Trial: 31654294
Drug: Elagolix 200
RxNorm normalized name: elagolix 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix 200 mg BID
Trial: 22646157
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg daily (loading dose 300 mg) plus indobufen 100 mg twice a day (group A)
Trial: 22646157
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg daily after 300 mg loading dose (group B)
Trial: 6751116
Drug: Praziquantel 60
RxNorm normalized name: praziquantel 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 60 mg/kg body weight in three divided doses orally
Trial: 30537752
Drug: Virtual Reality-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual Reality-based Tai Chi (VRTC) exercise program, conducted twice weekly for 6 months
Trial: 24628747
Drug: Hydrocodone/acetaminophen (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone/acetaminophen (5 mg/500 mg)
Trial: 24628747
Drug: Codeine/acetaminophen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/acetaminophen (30 mg/300 mg)
Trial: 1928881
Drug: Hydrocodone/acetaminophen
RxNorm normalized name: hydrocodone/acetaminophen 5 mg-500 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone/acetaminophen
Trial: 24186866
Drug: Metformin (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2,000 mg/day)
Trial: 12107206
Drug: im T
RxNorm normalized name: Trimethoprim Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: im T enanthate 100 mg/wk plus daily oral placebo (T)
Trial: 12107206
Drug: im placebo/wk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: im placebo/wk plus 125 microg daily oral levonorgestrel (LNG)
Trial: 10053098
Drug: rhuIL‐6 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhuIL‐6 plus G‐CSF
Trial: 8821076
Drug: Infusion-capsule
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion-capsule
Trial: 8821076
Drug: Infusion-infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion-infusion
Trial: 2286454
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (3 g p.o. each on the evening before and after the operation)
Trial: 25528977
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of health worker training, adolescent-friendly facility improvements, and broad information dissemination via community, schools, and mass media.
Trial: 25696357
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg twice-daily plus dietary counselling
Trial: 9773735
Drug: Pre‐lunch reduced‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐lunch reduced‐dose lispro (70%) before lunch and supper with supplemental lunchtime NPH and with a 6‐h interval until dinner
Trial: 9773735
Drug: Pre‐lunch reduced‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐lunch reduced‐dose lispro (70%) before lunch and supper with supplemental lunchtime NPH and with a 8‐h interval until dinner
Trial: 9773735
Drug: Usual‐dose lispro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual‐dose lispro alone
Trial: 7752178
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 or 100 mg/day)
Trial: 3136828
Drug: Single instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single instillation of 40 mg mitomycin C in 40 ml of water
Trial: 28657529
Drug: D-002 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-002 (50 mg once daily for 12 weeks)
Trial: 28657529
Drug: GS/CS (375/300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS/CS (375/300 mg once daily for 12 weeks)
Trial: 25555621
Drug: BNT+placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNT+placebo injection
Trial: 25555621
Drug: CE+placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE+placebo injection
Trial: 12544677
Drug: Oral HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HRT (equine conjugated estrogens 0.625 mg/day + dydrogesterone 5 mg/day in a continuous combined regimen)
Trial: 12544677
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not treated with hormones)
Trial: 29936125
Drug: Positive psychotherapy
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive psychotherapy for smoking cessation with transdermal nicotine patch and text messaging support
Trial: 29936125
Drug: Standard behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard behavioral smoking cessation counseling with transdermal nicotine patch and text messaging support
Trial: 26183669
Drug: Electronic daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic daily diary incorporating VVSymQ® instrument
Trial: 24528569
Drug: Reference group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference group (two sequential face-to-face consultations)
Trial: 18246681
Drug: Guipi Wan
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guipi Wan (Pill for Invigorating the Spleen and Nourishing the Heart)
Trial: 15046708
Drug: Metalloproteinase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metalloproteinase inhibitors
Trial: 26978413
Drug: meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meloxicam 15 mg/day
Trial: 22455403
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sildenafil on-demand exclusively
Trial: 17559108
Drug: Drug-eluting nitinol
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting nitinol stents
Trial: 10868163
Drug: Psychosocial treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatments
Trial: 23474270
Drug: Average daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Average daily energy intake
Trial: 88853
Drug: Bleomycin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleomycin therapy
Trial: 88853
Drug: Cryo-surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryo-surgical treatment
Trial: 20522841
Drug: Indacaterol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol (both doses)
Trial: 6829517
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific pharmacotherapy
Trial: 21719165
Drug: Standard glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard glucose infusion (SG; 5.0 mg kg(‐1) min(‐1))
Trial: 18329563
Drug: Propranolol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (30 mg)
Trial: 16401810
Drug: Emtricitabine 200
RxNorm normalized name: emtricitabine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emtricitabine 200 mg once daily for 48 weeks
Trial: 15536785
Drug: Locally delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locally delivered minocycline microspheres (Arestin) as an adjunct to scaling and root planing (SRP)
Trial: 3521401
Drug: Ethaverine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethaverine 200 mg four times daily
Trial: 17534380
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg nicotine
Trial: 17534380
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg nicotine
Trial: 24884787
Drug: Sitagliptin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin treatment (n=16)
Trial: 24884787
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (Control, n=10)
Trial: 22261813
Drug: Early passive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early passive therapy followed by active robot‐assisted intervention (HTI group, 10 sessions of passive therapy followed by 10 sessions of active therapy)
Trial: 10851101
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (4-week program focusing on strength and endurance of back and abdominal muscles)
Trial: 8671131
Drug: Electromagnetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electromagnetic therapy at 800 Hz
Trial: 8671131
Drug: Placebo therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo therapy or treatment with 600 Hz
Trial: 29745007
Drug: ASP0113 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP0113 (5 mg, 5 doses on Days 30/60/90/120/180 posttransplant)
Trial: 24718775
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg oral melatonin
Trial: 23302558
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine antibiotics treatment)
Trial: 8927671
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fluoxetine daily
Trial: 14714120
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg fluoxetine daily
Trial: 14714120
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fluoxetine once every third day
Trial: 12172973
Drug: Heptaplatin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heptaplatin 400 mg/m(2) i.v. over 1 h on day 1 plus 5‐fluorouracil (5‐FU) 1000 mg/m(2) per day continuous i.v. from day 1 to day 5
Trial: 11533324
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus acetazolamide and furosemide
Trial: 2196030
Drug: Curosurf (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curosurf (200 mg/kg) given intratracheally
Trial: 6315123
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone 200 mg daily
Trial: 6315123
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone 300 mg daily
Trial: 6315123
Drug: Conjugated oestrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated oestrogens 1.25 mg daily
Trial: 30558672
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no spacer injection)
Trial: 30558672
Drug: Subcutaneous spacer
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous spacer injection
Trial: 19808950
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg per day
Trial: 17484092
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg per day
Trial: 10023697
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) at 500 mg/body/day for 7 days
Trial: 10023697
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) at 500 mg/body/day for 5 days
Trial: 10023697
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) at 500 mg/body/day for 10 days
Trial: 6541929
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oxazolam with 0.55 g/kg alcohol
Trial: 6541929
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg oxazolam with 0.55 g/kg alcohol
Trial: 6541929
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oxazolam with 0.83 g/kg alcohol
Trial: 6541929
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with 0.55 g/kg alcohol
Trial: 27449412
Drug: GCSB-5 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCSB-5 600 mg, bid for 12 weeks
Trial: 22482863
Drug: LI-guided pre-emptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LI-guided pre-emptive therapy (group 3, n = 71)
Trial: 22482863
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (group 2, n = 142)
Trial: 1861917
Drug: Sulfisoxazole 75
RxNorm normalized name: Sulfisoxazole
DrugBank: Sulfisoxazole (DB00263)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfisoxazole 75 mg/kg per day for 6 months
Trial: 26765633
Drug: 2 g·d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g·d of DHA
Trial: 26765633
Drug: 4 g·d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g·d of DHA